tirzepatide dosage maintenance for the of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN Maintenance therapy on semaglutide or

In a first-of-its-kind trial, tirzepatide reduced severity of symptoms and improved heart failure outcomes in people with HFpEF and obesity. Multifaceted benefits in SUMMIT Unlike previous therapies, tirzepatide may address multiple aspects of HFpEF management simultaneously

However, inhibiting ferroptosis in hepatocytes can alleviate liver damage, suggesting that ferroptosis might represent a potential therapeutic target for HBV-ALF

It has been widely reported that nucleus accumbens core (NAc) is essential for mediating locomotor movements in rodents [32,33,34]

A three-minute method for high-throughput quantitative metabolomics and quantitative tracing experiments of central carbon and nitrogen pathways

Only the delivery mechanism differs